Compile Data Set for Download or QSAR
maximum 50k data
Found 278 with Last Name = 'schudok' and Initial = 'm'
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109847(US8609681, 70)
Affinity DataKi:  0.300nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109859(US8609681, 102)
Affinity DataKi:  0.5nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109858(US8609681, 97)
Affinity DataKi:  1nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109862(US8609681, 9)
Affinity DataKi:  1.80nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109857(US8609681, 94)
Affinity DataKi:  2nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109839(US8609681, 36)
Affinity DataKi:  2nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109856(US8609681, 91)
Affinity DataKi:  2nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109839(US8609681, 36)
Affinity DataKi:  3nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109862(US8609681, 9)
Affinity DataKi:  3.20nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109844(US8609681, 53)
Affinity DataKi:  4.5nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109846(US8609681, 63)
Affinity DataKi:  5nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109850(US8609681, 77)
Affinity DataKi:  7nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109845(US8609681, 56)
Affinity DataKi:  7.20nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109845(US8609681, 56)
Affinity DataKi:  7.5nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109854(US8609681, 83)
Affinity DataKi:  8nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109852(US8609681, 79)
Affinity DataKi:  9nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109853(US8609681, 80)
Affinity DataKi:  9nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109855(US8609681, 88)
Affinity DataKi:  9nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109841(US8609681, 42)
Affinity DataKi:  11nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50148952(CHEMBL429152 | N-[4-(1-{2-[3-(4-Carbamimidoyl-phen...)
Affinity DataKi:  12nMAssay Description:In vitro inhibition of human coagulation factor VIIaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50148947(CHEMBL339880 | Piperidine-4-carboxylic acid [4-(1-...)
Affinity DataKi:  13nMAssay Description:In vitro inhibition of human coagulation factor VIIaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109840(US8609681, 37)
Affinity DataKi:  13nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50148950(CHEMBL332753 | N-[1-(3-Bromo-4-morpholin-4-yl-phen...)
Affinity DataKi:  15nMAssay Description:In vitro inhibition of human coagulation factor VIIaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109855(US8609681, 88)
Affinity DataKi:  15nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109843(US8609681, 49)
Affinity DataKi:  16nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109852(US8609681, 79)
Affinity DataKi:  16nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109848(US8609681, 74)
Affinity DataKi:  16nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109851(US8609681, 78)
Affinity DataKi:  19nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50148945(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(3-m...)
Affinity DataKi:  20nMAssay Description:In vitro inhibition of human coagulation factor VIIaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109850(US8609681, 77)
Affinity DataKi:  20nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50148953(4-(1-{2-[3-(4-Carbamimidoyl-phenyl)-ureido]-acetyl...)
Affinity DataKi:  20nMAssay Description:In vitro inhibition of human coagulation factor VIIaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109842(US8609681, 45)
Affinity DataKi:  21nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109840(US8609681, 37)
Affinity DataKi:  21nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109846(US8609681, 63)
Affinity DataKi:  22nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109849(US8609681, 76)
Affinity DataKi:  22nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126575(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(3-oxo-...)
Affinity DataKi:  23nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50148958(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(3-c...)
Affinity DataKi:  23nMAssay Description:In vitro inhibition of human coagulation factor VIIaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109857(US8609681, 94)
Affinity DataKi:  24nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109842(US8609681, 45)
Affinity DataKi:  24nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50148949(CHEMBL339200 | N-[4-(1-{2-[3-(4-Carbamimidoyl-phen...)
Affinity DataKi:  26nMAssay Description:In vitro inhibition of human coagulation factor VIIaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50148960(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((S)-1-nap...)
Affinity DataKi:  26nMAssay Description:In vitro inhibition of human coagulation factor VIIaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126571(CHEMBL35586 | N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[...)
Affinity DataKi:  27nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109860(US8609681, 103)
Affinity DataKi:  27nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin S. This protein is obtained as an inactive enzyme from R&D Systems...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126571(CHEMBL35586 | N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[...)
Affinity DataKi:  27nMAssay Description:In vitro inhibition of human coagulation factor VIIaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126572(CHEMBL35754 | N-[1-(2,4-Bis-trifluoromethyl-phenyl...)
Affinity DataKi:  27nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109854(US8609681, 83)
Affinity DataKi:  28nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor VII(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50148954(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(4-morp...)
Affinity DataKi:  30nMAssay Description:In vitro inhibition of human coagulation factor VIIaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109861(US8609681, 35)
Affinity DataKi:  31nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109841(US8609681, 42)
Affinity DataKi:  32nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM109859(US8609681, 102)
Affinity DataKi:  33nMAssay Description:Determination of the enzymatic activity of the catalytic domain of human Cathepsin K. This protein is obtained as an inactive enzyme from Sanofi-Aven...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 278 total ) | Next | Last >>
Jump to: